SOX2 and head and neck squamous cell carcinoma: In an “in vivo study”, SOX2 expression in HNSCC tumor cells led to a decrease in CD8+ T-lymphocyte infiltration and promoted tumor growth through the suppression of stimulation of interferon genes (STING)-dependent interferon-I-mediated signaling.